Key points for WELL & US Market WELL's first acquisition in the US was in October 2020 with Circle Medical.
At that time, Circle had a revenue run-rate of 5,7 M$ USD per YEAR.
Circle Medical generated OVER 1 M$ USD in NOVEMBER ONLY. The analysts had estimated 550 000 $ USD.
Circle Medical was acquired with 5,7 M$ a year in revenues, and already seems to have reached a 12 M$ USD revenue run-rate.
Next key milestones for WELL in my opinion :
- A second US based acquisition : stronger presence in the US by Q2 - 2021
- Uplisting on the Nasdaq by Q3 - 2021
Being traded on the US side, will bring an incredible exposure and bring to much higher valuations.
WELL has an advantage on any other Telehealth stock I know, they grow fast while still reaching PROFITABILITY. This will be proven in Q1 & Q2 - 2021.
Cheers